PMID- 36773673 OWN - NLM STAT- MEDLINE DCOM- 20230315 LR - 20230315 IS - 1872-8227 (Electronic) IS - 0168-8227 (Linking) VI - 197 DP - 2023 Mar TI - Severe distress & denial among Asian patients with Type 2 Diabetes Mellitus in the primary care: A prospective, multicentre study. PG - 110574 LID - S0168-8227(23)00049-9 [pii] LID - 10.1016/j.diabres.2023.110574 [doi] AB - AIMS: To determine the point-prevalence and distribution of diabetes distress among primary care Asians with Type 2 Diabetes Mellitus (T2DM) and evaluate its association with cardiovascular risk. METHODS: This was a prospective, multicentre study conducted in two outpatient clinics. Patients aged >/= 21 years with uncontrolled T2DM (HbA1c > 7.0 % [53 mmol/mol]) and polypharmacy were stratified based on their Framingham Risk Score (FRS-high >/= 10 %, low < 10 %) and matched in accordance to their baseline HbA1c. Cardiovascular risk was estimated using FRS while diabetes distress was measured using Problem Areas in Diabetes (PAID) scale (denial 0-10, severe distress >/= 40). RESULTS: Of 1940 patients approached, 210 were recruited. A final 132 (62.9 %) participants were eligible for analysis. Median PAID score was 17.5 (IQR 6.25-41.56), with an even distribution in each distress category. There was no significant difference in PAID scores between the high and low FRS groups (20.00vs13.75, p = 0.446). Additionally, PAID score distribution within each group was similar (McNemar-Bowker test, p = 0.477). However, a high prevalence of severe distress (31.4 %) and denial (33.8 %) was detected. Among those in denial, 58.7 % had accompanying intermediate-high 10-year cardiovascular risk. CONCLUSION: In our sample of Asian primary care patients, a high prevalence of severe diabetes distress and denial was detected although no clear association between cardiovascular risk and diabetes distress was found. Future studies should assess the longitudinal changes and impact of other risk factors in diabetes distress. (Abstract: 199 words). CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Tan, Cheryl Wei Yan AU - Tan CWY AD - National Healthcare Group Pharmacy, Singapore; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore. Electronic address: Cheryl_Wy_TAN@pharmacy.nhg.com.sg. FAU - Xu, Yingqi AU - Xu Y AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore; Health Services Research Centre, Singapore Health Services, Singapore. FAU - Lee, Joyce Yu-Chia AU - Lee JY AD - Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore; School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine. Electronic address: j.lee@uci.edu. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20230209 PL - Ireland TA - Diabetes Res Clin Pract JT - Diabetes research and clinical practice JID - 8508335 RN - 0 (Glycated Hemoglobin) SB - IM MH - Humans MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Glycated Hemoglobin MH - Prospective Studies MH - Risk Factors MH - Primary Health Care OTO - NOTNLM OT - Cardiovascular OT - Chronic disease OT - Emotional OT - Primary health care OT - Psychological COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2023/02/12 06:00 MHDA- 2023/03/16 06:00 CRDT- 2023/02/11 19:23 PHST- 2020/02/12 00:00 [received] PHST- 2023/01/29 00:00 [revised] PHST- 2023/02/05 00:00 [accepted] PHST- 2023/02/12 06:00 [pubmed] PHST- 2023/03/16 06:00 [medline] PHST- 2023/02/11 19:23 [entrez] AID - S0168-8227(23)00049-9 [pii] AID - 10.1016/j.diabres.2023.110574 [doi] PST - ppublish SO - Diabetes Res Clin Pract. 2023 Mar;197:110574. doi: 10.1016/j.diabres.2023.110574. Epub 2023 Feb 9.